ABEO Quote, Trading Chart, Abeona Therapeutics Inc.
home / stock / abeo / abeo quote
$2.01 Last:
-3.37% Change Percent:
$2.1 Open:
$2.01 Previous Close:
$2.14 High:
$1.695 Low:
3,908,937 Volume:
03/05/2021 04:55:13 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 2.1 | 2.01 | 2.14 | 1.695 | 3,908,937 |
| 2021-03-04 | 2.19 | 2.08 | 2.27 | 1.925 | 4,590,062 |
| 2021-03-03 | 2.38 | 2.19 | 2.4 | 2.16 | 3,623,699 |
| 2021-03-02 | 2.36 | 2.36 | 2.5 | 2.32 | 2,706,952 |
| 2021-03-01 | 2.55 | 2.34 | 2.579 | 2.32 | 4,748,210 |
| 2021-02-26 | 2.67 | 2.42 | 2.87 | 2.3619 | 14,023,738 |
| 2021-02-25 | 2.148 | 2.49 | 2.84 | 2.13 | 17,336,807 |
| 2021-02-24 | 2.15 | 2.2 | 2.32 | 2.15 | 2,750,412 |
| 2021-02-23 | 2.14 | 2.1 | 2.17 | 1.88 | 4,947,435 |
| 2021-02-22 | 2.36 | 2.23 | 2.43 | 2.23 | 3,215,937 |
| 2021-02-19 | 2.49 | 2.41 | 2.5001 | 2.32 | 3,514,834 |
| 2021-02-18 | 2.41 | 2.46 | 2.52 | 2.25 | 4,261,548 |
| 2021-02-17 | 2.6 | 2.63 | 2.72 | 2.125 | 12,339,725 |
| 2021-02-16 | 3 | 2.72 | 3.09 | 2.71 | 7,197,860 |
| 2021-02-15 | 3.3217 | 2.96 | 3.75 | 2.87 | 16,989,947 |
| 2021-02-12 | 3.3217 | 2.96 | 3.75 | 2.87 | 16,840,046 |
| 2021-02-11 | 3.455 | 3.36 | 3.55 | 3.08 | 7,080,464 |
| 2021-02-10 | 3.28 | 3.36 | 3.45 | 2.86 | 8,916,566 |
| 2021-02-09 | 3.7899 | 3.34 | 3.7899 | 3.2 | 11,619,462 |
| 2021-02-08 | 2.67 | 3.39 | 3.5 | 2.62 | 16,365,545 |
Abeona Therapeutics Inc. Company Name:
ABEO Stock Symbol:
NASDAQ Market:
Abeona Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
NEW YORK and CLEVELAND, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the company will present at the 10 th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 20...
-
In addition to preservation of neurocognitive development with ABO-102 in MPS IIIA, new clinical results of ABO-102 in MPS IIIA and ABO-101 in MPS IIIB continue to show dose-dependent and sustained reductions in disease-specific biomarkers, denoting clear biologic effects In add...
-
Monday, February 8th, marked a new week for penny stocks . Overall, the stock market saw a large bullish jump seemingly across the board. In the past six months, both blue-chip and penny stocks have gained quite a lot of momentum. In that time, virus case numbers have also been quite vo...